on EvoNext Holdings SA (ETR:EVE)
EvoNext Holdings SA Releases 2025 Annual Report
EvoNext Holdings SA has published its full-year report for 2025. As of December 31, 2025, the company reported total liquidity of CHF 5.9 million, with most of it held in cash. Despite recording an operating loss of CHF 0.7 million due to transaction search expenses, the company maintained a low cash burn rate.
The arbitration with B&D Nutritional Ingredients has resolved in EvoNext's favor, awarding the company the right to collect approximately USD 568,650. However, EvoNext's ability to collect these funds fully remains uncertain due to the financial state of B&D.
Throughout 2025, EvoNext explored various mergers and acquisitions, focusing on reverse takeovers. However, no agreements were reached. The board remains focused on identifying suitable M&A opportunities to support future growth.
The company's AGM for 2026 is scheduled for May 20, and can be accessed via the Swiss Official Gazette of Commerce and the company's website.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EvoNext Holdings SA news